United Arab Emirates
· Delayed Price · Currency is AED DFM:NIH Statistics
Total Valuation
DFM:NIH has a market cap or net worth of AED 458.10 million. The enterprise value is 523.94 million.
| Market Cap | 458.10M |
| Enterprise Value | 523.94M |
Important Dates
The last earnings date was Thursday, March 20, 2025.
| Earnings Date | Mar 20, 2025 |
| Ex-Dividend Date | Jul 9, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.24% |
| Shares Change (QoQ) | +1.59% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 145.49M |
Valuation Ratios
The trailing PE ratio is 23.45.
| PE Ratio | 23.45 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 0.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.63, with an EV/FCF ratio of -37.09.
| EV / Earnings | 26.82 |
| EV / Sales | 5.38 |
| EV / EBITDA | 11.63 |
| EV / EBIT | 12.20 |
| EV / FCF | -37.09 |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.65 |
| Quick Ratio | 1.53 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.60 |
| Debt / FCF | -1.91 |
| Interest Coverage | 16.42 |
Financial Efficiency
Return on equity (ROE) is 3.92% and return on invested capital (ROIC) is 4.52%.
| Return on Equity (ROE) | 3.92% |
| Return on Assets (ROA) | 4.03% |
| Return on Invested Capital (ROIC) | 4.52% |
| Return on Capital Employed (ROCE) | 7.27% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.15 |
| Inventory Turnover | 3.95 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +42.07% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +42.07% |
| 50-Day Moving Average | 2.90 |
| 200-Day Moving Average | 2.55 |
| Relative Strength Index (RSI) | 39.95 |
| Average Volume (20 Days) | 18,024 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DFM:NIH had revenue of AED 97.42 million and earned 19.54 million in profits. Earnings per share was 0.09.
| Revenue | 97.42M |
| Gross Profit | 62.36M |
| Operating Income | 42.96M |
| Pretax Income | 22.23M |
| Net Income | 19.54M |
| EBITDA | 45.10M |
| EBIT | 42.96M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 64.94 million in cash and 26.97 million in debt, giving a net cash position of 37.97 million.
| Cash & Cash Equivalents | 64.94M |
| Total Debt | 26.97M |
| Net Cash | 37.97M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 564.39M |
| Book Value Per Share | 1.98 |
| Working Capital | 51.42M |
Cash Flow
In the last 12 months, operating cash flow was -13.17 million and capital expenditures -957,568, giving a free cash flow of -14.12 million.
| Operating Cash Flow | -13.17M |
| Capital Expenditures | -957,568 |
| Free Cash Flow | -14.12M |
| FCF Per Share | n/a |
Margins
Gross margin is 64.01%, with operating and profit margins of 44.10% and 20.06%.
| Gross Margin | 64.01% |
| Operating Margin | 44.10% |
| Pretax Margin | 22.82% |
| Profit Margin | 20.06% |
| EBITDA Margin | 46.29% |
| EBIT Margin | 44.10% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 3.49%.
| Dividend Per Share | 0.07 |
| Dividend Yield | 3.49% |
| Dividend Growth (YoY) | 20.31% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 80.45% |
| Buyback Yield | -0.24% |
| Shareholder Yield | 3.25% |
| Earnings Yield | 4.27% |
| FCF Yield | -3.08% |
Stock Splits
The last stock split was on July 19, 2022. It was a forward split with a ratio of 1.03.
| Last Split Date | Jul 19, 2022 |
| Split Type | Forward |
| Split Ratio | 1.03 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |